Article info
Therapeutics/Prevention
Systematic review
Evidence is weak to support hepatocellular carcinoma screening in chronic liver disease
- Correspondence to: Professor Simon D Taylor-Robinson, Department of Medicine, 10th Floor QEQM Wing, St Mary's Hospital Campus, Imperial College London, South Wharf Street, London W2 1NY, UK; s.taylor-robinson{at}imperial.ac.uk
Citation
Evidence is weak to support hepatocellular carcinoma screening in chronic liver disease
Publication history
- First published February 18, 2015.
Online issue publication
March 17, 2015
Article Versions
- Previous version (18 February 2015).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions